Three-Pronged attack on deadly leukemia aims for cure
NCT ID NCT01409161
Summary
This study is testing a combination of three drugs to try to cure patients with a specific, aggressive type of leukemia called acute promyelocytic leukemia (APL). The goal is to see if using these drugs together can eliminate the cancer for good, allowing patients to stop treatment and remain healthy. The trial is for 151 adults who have not yet received treatment for their APL.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE PROMYELOCYTIC LEUKEMIA WITH PML-RARA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
M D Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-••••
Contact
-
MD Anderson Regional Care Center-Bay Area
RECRUITINGNassau Bay, Texas, 77058, United States
Contact Phone: •••-•••-••••
Contact
-
MD Anderson Regional Care Center-Katy
RECRUITINGHouston, Texas, 77094, United States
Contact Phone: •••-•••-••••
Contact
-
MD Anderson Regional Care Center-Sugar Land
RECRUITINGSugar Land, Texas, 77478, United States
Contact Phone: •••-•••-••••
Contact
-
MD Anderson Regional Care Center-The Woodlands
RECRUITINGThe Woodlands, Texas, 77384, United States
Contact Phone: •••-•••-••••
Contact
Conditions
Explore the condition pages connected to this study.